You are here

Sosei Heptares

Pfizer advances diabetes, obesity drug hopeful into mid-stage testing

BioPharma Dive

Wed, 12/21/22 - 12:34 pm

AbbVie gives Sosei a StaRring role in neurological drug discovery plans, paying $40M and committing $1.2B

Fierce Biotech

Tue, 08/2/22 - 10:48 am

neurological disorders

GlaxoSmithKline joins Sosei's who's-who list of clients with global licensing pact for IBD small molecules

Endpoints

Sun, 12/20/20 - 11:02 pm

inflammatory bowel disease

Sosei pens inflammatory and autoimmune disease drug pact with AbbVie

Fierce Biotech

Thu, 06/25/20 - 10:47 am

Takeda, Sosei form gastrointestinal disease R&D pact

Fierce Biotech

Mon, 08/5/19 - 10:43 am

gastrointestinal disease

Roche's Genentech goes on deal spree, unveiling third deal on the same day

Endpoints

Tue, 07/16/19 - 10:57 am

Skyhawk Therapeutics

Convelo Therapeutics

Pfizer selects first GPCR candidate from Sosei Heptares tie-up

Pharmaforum

Tue, 05/14/19 - 09:53 am

drug development